{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:09:02Z","timestamp":1785506942965,"version":"3.56.0"},"reference-count":26,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Thyroid cancer incidence is rising worldwide, yet comprehensive longitudinal data linking contemporary demographic, pathological, and surgical trends to recurrence risk remain scarce.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis was performed on 9504 thyroid cancer patients from 2008 to 2023. Based on the year of treatment, patients were categorized into 3 groups for comparative assessment. Demographic features, clinical pathological characteristics, surgical approaches, and prognostic outcomes were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over the 16-year period, the annual number of new thyroid cancer cases demonstrated a consistent upward trend, with a growing proportion detected through routine health screenings. The male-to-female ratio was 1:2.76, with a gradual increase in male patients. The peak age at diagnosis remained between 30 and 60 years, while the proportion of juvenile patients declined steadily. Papillary thyroid carcinoma constituted the predominant histologic type. Surgical management shifted toward more conservative approaches. Although tumor size decreased over time, the incidence of multifocal lesions and the BRAF V600E mutation rate rose. Lymph node metastasis rates also increased, particularly in patients with central region metastases and metastases in \u22645 lymph nodes. Multivariate analysis identified age, tumor size, and number of metastatic lymph nodes as independent risk factors for recurrence in papillary thyroid carcinoma. Patients older than 55 years, those with larger lesions, or those with more lymph node metastases exhibited a significantly elevated recurrence risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although thyroid cancers are being detected at earlier stages and smaller sizes, the burdens of molecular, multifocal, and lymph node disease are increasing. Age, tumor size, and nodal metastatic load constitute robust independent predictors of recurrence in papillary thyroid carcinoma, informing risk-adapted surveillance and surgical strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/jendso\/bvag153","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T10:41:12Z","timestamp":1783334472000},"source":"Crossref","is-referenced-by-count":1,"title":["Clinical and pathological profile with prognostic insights in 9504 thyroid cancer cases: a single-center study (2008-2023)"],"prefix":"10.1210","volume":"10","author":[{"given":"Sijin","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, The Fourth Military Medical University , Xi\u2019an, Shaanxi 710032 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, The Fourth Military Medical University , Xi\u2019an, Shaanxi 710032 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3414-2130","authenticated-orcid":false,"given":"Changjiao","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, The Fourth Military Medical University , Xi\u2019an, Shaanxi 710032 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4121-7532","authenticated-orcid":false,"given":"Ting","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, The Fourth Military Medical University , Xi\u2019an, Shaanxi 710032 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"issue":"5","key":"2026073109214133000_bvag153-B1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.2023.26348","article-title":"Thyroid cancer: a review","volume":"331","author":"Boucai","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"2026073109214133000_bvag153-B2","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J Natl Cancer Cent"},{"issue":"13","key":"2026073109214133000_bvag153-B3","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in thyroid cancer incidence and mortality in the United States, 1974-2013","volume":"317","author":"Lim","year":"2017","journal-title":"JAMA"},{"issue":"11","key":"2026073109214133000_bvag153-B4","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"issue":"3","key":"2026073109214133000_bvag153-B5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.14639\/0392-100X-N1412","article-title":"Predictive factors for recurrence of papillary thyroid carcinoma: analysis of 4,085 patients","volume":"41","author":"Ywata de Carvalho","year":"2021","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"2","key":"2026073109214133000_bvag153-B6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000504961","article-title":"Systematic review of recurrence rate after hemithyroidectomy for low-risk well-differentiated thyroid cancer","volume":"9","author":"Chan","year":"2020","journal-title":"Eur Thyroid J"},{"issue":"1","key":"2026073109214133000_bvag153-B7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13044-022-00130-8","article-title":"Sporadic medullary thyroid cancer: a systematic review and meta-analysis of clinico-pathological and mutational characteristics predicting recurrence","volume":"15","author":"Cosway","year":"22 2022","journal-title":"Thyroid Res"},{"issue":"9","key":"2026073109214133000_bvag153-B8","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.21037\/tcr-20-1364","article-title":"Long-term survival of patients with anaplastic thyroid cancer after multimodal treatment","volume":"9","author":"Lee","year":"2020","journal-title":"Transl Cancer Res"},{"issue":"8","key":"2026073109214133000_bvag153-B9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"American thyroid association management guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"key":"2026073109214133000_bvag153-B10","doi-asserted-by":"crossref","unstructured":"Guo S, Wang Y, Yan C, et al \u00a0Clinical and Pathological Profile with Prognostic Insights in 9504 Thyroid Cancer Cases: A Single-Center Study (2008-2023). Figshare, 2026. Deposited. 10.6084\/m9.figshare.32274615.","DOI":"10.1210\/jendso\/bvag153"},{"issue":"3","key":"2026073109214133000_bvag153-B11","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"2026073109214133000_bvag153-B12","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.21037\/gs-21-545","article-title":"Sex disparities in thyroid cancer: a SEER population study","volume":"10","author":"Li","year":"2021","journal-title":"Gland Surg"},{"issue":"1","key":"2026073109214133000_bvag153-B13","doi-asserted-by":"crossref","first-page":"25538","DOI":"10.1038\/s41598-024-77663-5","article-title":"Temporal trends of thyroid cancer in China and globally from 1990 to 2021: an analysis of the global burden of disease study 2021","volume":"14","author":"Huang","year":"26 2024","journal-title":"Sci Rep"},{"key":"2026073109214133000_bvag153-B14","doi-asserted-by":"crossref","first-page":"5544232","DOI":"10.1155\/2021\/5544232","article-title":"The overdiagnosis of thyroid micropapillary carcinoma: the rising incidence, inert biological behavior, and countermeasures","volume":"2021","author":"Xu","year":"2021","journal-title":"J Oncol"},{"key":"2026073109214133000_bvag153-B15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fendo.2019.00074","article-title":"Papillary thyroid micro carcinoma: the incidence of high-risk features and its prognostic implications","volume":"10","author":"Gao","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2026073109214133000_bvag153-B16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12885-017-3120-0","article-title":"Papillary thyroid microcarcinoma: the significance of high risk features","volume":"17","author":"Bradley","year":"2017","journal-title":"BMC Cancer"},{"issue":"4","key":"2026073109214133000_bvag153-B17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1530\/ERC-15-0152","article-title":"Identification of occult tumors by whole-specimen mapping in solitary papillary thyroid carcinoma","volume":"22","author":"Park","year":"2015","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"2026073109214133000_bvag153-B18","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2217\/fon.16.10","article-title":"Nodal metastases in thyroid cancer: prognostic implications and management","volume":"12","author":"Wang","year":"2016","journal-title":"Future Oncol (London, England)"},{"issue":"9","key":"2026073109214133000_bvag153-B19","first-page":"5393","article-title":"Risk factors influencing the recurrence of papillary thyroid carcinoma: a systematic review and meta-analysis","volume":"7","author":"Guo","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"2026073109214133000_bvag153-B20","doi-asserted-by":"crossref","first-page":"1484838","DOI":"10.3389\/fendo.2024.1484838","article-title":"The diagnosis and management of small and indeterminate lymph nodes in papillary thyroid cancer: preoperatively and intraoperatively","volume":"15","author":"Hu","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2026073109214133000_bvag153-B21","first-page":"181","article-title":"Guidelines for the diagnosis and management of thyroid nodules and differentiated thyroid cancer (second edition)","volume":"39","author":"CSo","year":"2023","journal-title":"Chin J Endocrinol Metab"},{"key":"2026073109214133000_bvag153-B22","doi-asserted-by":"crossref","first-page":"1268282","DOI":"10.3389\/fendo.2023.1268282","article-title":"Risk factors and predictive model for recurrence in papillary thyroid carcinoma: a single-center retrospective cohort study based on 955 cases","volume":"14","author":"Li","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2026073109214133000_bvag153-B23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.eprac.2021.09.001","article-title":"Can age at diagnosis and sex improve the performance of the American thyroid association risk stratification system for prediction of structural persistent and recurrent disease in patients with differentiated thyroid carcinoma? A multicenter study","volume":"28","author":"Zuhur","year":"2022","journal-title":"Endocr Pract"},{"key":"2026073109214133000_bvag153-B24","doi-asserted-by":"crossref","first-page":"110392","DOI":"10.1016\/j.clinimag.2024.110392","article-title":"Predicting lymph node metastasis in thyroid cancer: systematic review and meta-analysis on the CT\/MRI-based radiomics and deep learning models","volume":"119","author":"Valizadeh","year":"2025","journal-title":"Clin Imaging"},{"issue":"8","key":"2026073109214133000_bvag153-B25","doi-asserted-by":"crossref","first-page":"bvae131","DOI":"10.1210\/jendso\/bvae131","article-title":"Association of lymph nodes positive rate with the risk of recurrence in patients with stage T1 papillary thyroid cancer","volume":"8","author":"Qin","year":"1 2024","journal-title":"J Endocr Soc"},{"issue":"1","key":"2026073109214133000_bvag153-B26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12893-024-02564-3","article-title":"Risk factors and distribution pattern of lateral lymph node recurrence after central neck dissection for cN1a papillary thyroid carcinoma","volume":"24","author":"Long","year":"27 2024","journal-title":"BMC Surg"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvag153\/68700453\/bvag153.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/8\/bvag153\/68700453\/bvag153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/8\/bvag153\/68700453\/bvag153.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T13:21:49Z","timestamp":1785504109000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvag153\/8725315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,7,8]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvag153","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,7,6]]},"article-number":"bvag153"}}